Linearis Ventures is a fund igniting precision medicine by supporting early-stage discoveries along the health continuum. Through its innovation arm at the intersection of artificial intelligence and biomarker analysis, Linearis Labs promotes research and product development for screening, treatment monitoring, and drug discovery tackling metabolic diseases including cancer, diabetes and others.